AAAAAA
Results:
1-17
|
Results: 17
Authors:
Sakharova, OV
Taal, MW
Brenner, BM
Citation: Ov. Sakharova et al., Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor, CURR OP NEP, 10(6), 2001, pp. 727-738
Authors:
Taal, MW
Brenner, BM
Citation: Mw. Taal et Bm. Brenner, Evolving strategies for renoprotection: non-diabetic chronic renal disease, CURR OP NEP, 10(4), 2001, pp. 523-531
Authors:
Taal, MW
Nenov, VD
Wong, WC
Satyal, SR
Sakharova, O
Choi, JH
Troy, JL
Brenner, BM
Citation: Mw. Taal et al., Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone, J AM S NEPH, 12(10), 2001, pp. 2051-2059
Authors:
Taal, MW
Chertow, GM
Rennke, HG
Gurnani, A
Jiang, T
Shahsafaei, A
Troy, JL
Brenner, BM
Mackenzie, HS
Citation: Mw. Taal et al., Mechanisms underlying renoprotection during renin-angiotensin system blockade, AM J P-REN, 280(2), 2001, pp. F343-F355
Authors:
Taal, MW
Brenner, BM
Citation: Mw. Taal et Bm. Brenner, Achieving maximal renal protection in nondiabetic chronic renal disease, AM J KIDNEY, 38(6), 2001, pp. 1365-1371
Authors:
Taal, MW
van Zyl-Smit, R
Citation: Mw. Taal et R. Van Zyl-smit, Cost-effectiveness of hepatitis B vaccination in haemodialysis patients, S AFR MED J, 91(4), 2001, pp. 340-344
Authors:
Taal, MW
Singh, AK
Citation: Mw. Taal et Ak. Singh, Diagnostics and techniques, CURR OP NEP, 9(6), 2000, pp. 649-650
Authors:
Taal, MW
Citation: Mw. Taal, Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?, CURR OP NEP, 9(6), 2000, pp. 651-657
Authors:
Taal, MW
Omer, SA
Nadim, MK
Mackenzie, HS
Citation: Mw. Taal et al., Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression, CURR OP NEP, 9(4), 2000, pp. 323-331
Authors:
Nenov, VD
Taal, MW
Sakharova, OV
Brenner, BM
Citation: Vd. Nenov et al., Multi-hit nature of chronic renal disease, CURR OP NEP, 9(2), 2000, pp. 85-97
Authors:
Taal, MW
van Zyl-Smit, R
Citation: Mw. Taal et R. Van Zyl-smit, Hepatitis C virus infection in chronic haemodialysis patients - Relationship to blood transfusions and dialyser re-use, S AFR MED J, 90(6), 2000, pp. 621-625
Authors:
Taal, MW
Zandi-Nejad, K
Weening, B
Shahsafaei, A
Kato, S
Lee, KW
Ziai, F
Jiang, T
Brenner, BM
Mackenzie, HS
Citation: Mw. Taal et al., Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney, KIDNEY INT, 58(4), 2000, pp. 1664-1676
Authors:
Taal, MW
Brenner, BM
Citation: Mw. Taal et Bm. Brenner, Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists, KIDNEY INT, 57(5), 2000, pp. 1803-1817
Authors:
Mackenzie, HS
Ziai, F
Omer, SA
Nadim, MK
Taal, MW
Citation: Hs. Mackenzie et al., Angiotensin receptor blockers in chronic renal disease: The promise of a bright clinical future, J AM S NEPH, 10(4), 1999, pp. S283-S286
Authors:
Taal, MW
Brenner, BM
Citation: Mw. Taal et Bm. Brenner, ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models, J HUM HYPER, 13, 1999, pp. S51-S56
Authors:
Taal, MW
Cassidy, MJD
Pearson, D
Green, D
Masud, T
Citation: Mw. Taal et al., Usefulness of quantitative heel ultrasound compared with dual-energy X-rayabsorptiometry in determining bone mineral density in chronic haemodialysis patients, NEPH DIAL T, 14(8), 1999, pp. 1917-1921
Authors:
Taal, MW
Masud, T
Green, D
Cassidy, MJD
Citation: Mw. Taal et al., Risk factors for reduced bone density in haemodialysis patients, NEPH DIAL T, 14(8), 1999, pp. 1922-1928
Risultati:
1-17
|